Survival of patients with head and neck cancer with metachronous multiple primary tumors is surprisingly favorable.
Oisín BugterDirk L P van IwaardenEmilie A C DronkersMartine J de HerdtMarjan H WieringaGerda M VerduijnMarc A M MureauIvo Ten HoveEsther van MeertenJosé A HardilloRobert J Baatenburg de JongPublished in: Head & neck (2019)
One of 10 patients with HNSCC develop MPTs in the HN-region, lung, or esophagus. The 5-year survival of patients with metachronous HN MPTs was surprisingly favorable.
Keyphrases